|
HARTFORD, Conn., May 01, 2008 — Aetna (NYSE: AET) today announced its support of passage of the Genetic Information Nondiscrimination Act (GINA). Protecting the privacy of genetic information has been at the top of Aetna’s agenda for the past six years. GINA is consistent with Aetna’s commitment to providing members with access to optimal care. Medically appropriate genetic testing provides an opportunity to achieve that goal. The company also appreciates its obligation to protect the confidentiality of all individually identifiable health information, including genetic information, and has long supported the position that predictive genetic information should not be used to determine eligibility for health insurance coverage or set premiums. In 2002, the company was the first health plan to craft and implement a privacy policy describing appropriate and inappropriate uses of genetic data. The guidelines state that Aetna will:
Further, the company’s guidelines state that Aetna will not:
Aetna’s position served as the basis for the policy adopted by America’s Health Insurance Plans and is now an industry standard. In 2007, Aetna adopted an employment genetic non-discrimination policy. Aetna has developed a range of policies and tools to promote the evidence-based use of genetic technologies and services, including genetic counseling. Most recently, Aetna made available telephone and web-based genetic cancer counseling services for inherited cancers through Informed Medical Decisions, a national genetic counseling company staffed with board-certified genetic counselors with expertise in cancer genetic counseling. About Aetna |
